ClinicalTrials.Veeva
Menu

Find clinical trials for Alzheimer's Disease in Warszawa, Mazowieckie

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Alzheimer Disease
Dementia
Cognitive Dysfunction
Mental Disorders
Psychotic Disorders
Brain Diseases
Neurodegenerative Diseases

Alzheimer's Disease trials near Warszawa, Mazowieckie, POL:

Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD) (PRImus-AD)

Alzheimer's disease (AD) is the most common form of dementia. In the brains of people with AD, certain small substances stick toget ...

Active, not recruiting
Mild Cognitive Impairment Due to Alzheimer's Disease
Alzheimer's Disease, Early Onset
Drug: Placebo
Drug: PRI-002

Phase 2

PRInnovation

Warsaw, Poland and 38 other locations

The purpose of this study is to assess the safety, tolerability and effect of study drug LY3372689 in participants with early symptomatic Alzheimer's...

Active, not recruiting
Alzheimer Disease
Drug: LY3372689
Drug: Placebo

Phase 2

Lilly
Lilly

Warszawa, Mazowieckie, Poland and 69 other locations

versus (vs) placebo on the Clinical Dementia Rating Scale Sum of Boxes (CDR-SB) up to Week 80 in study participants with prodromal or mild Alzheimer's...

Active, not recruiting
Alzheimer's Disease
Other: Placebo
Biological: Bepranemab

Phase 2

UCB
UCB

Warszawa, Poland and 102 other locations

capsules (KarX-EC) in participants with agitation associated with Alzheimer's Disease who completed the parent studies CN012-0023 o...

Begins enrollment in 5 months
Alzheimer Disease
Agitation
Drug: KarX-EC
Drug: KarXT

Phase 3

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Sochaczew, Poland and 162 other locations

This AR1001-ADP3-US01 protocol is a double-blind, randomized, placebo-controlled, multi- center, parallel-group comparison pivotal Phase 3 study to e...

Active, not recruiting
Alzheimer Disease
Drug: Placebo
Drug: AR1001

Phase 3

AriBio

Warszawa, Poland and 103 other locations

This clinical trial is recruiting people who either are at risk of AD - have build-up of beta-amyloid, but have no clinical symptoms, or with a diagn...

Active, not recruiting
Alzheimer's Disease
Drug: RO7269162
Drug: Placebo

Phase 2

Roche
Roche

Warszawa, Poland and 55 other locations

In this study, researchers will learn more about a study drug called BIIB080. The study will focus on participants with mild cognitive impairment or...

Active, not recruiting
Mild Cognitive Impairment Due to Alzheimer's Disease
Alzheimer's Disease Dementia
Drug: BIIB080-matching placebo
Drug: BIIB080

Phase 2

Biogen
Biogen

Warszawa, Poland and 137 other locations

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease...

Active, not recruiting
Alzheimer Disease
Drug: Donanemab
Drug: Placebo

Phase 3

Lilly
Lilly

Warszawa, Mazowieckie, Poland and 275 other locations

The reason for this study is to assess the safety and efficacy of donanemab in participants with early Alzheimer's disease. The stu...

Enrolling
Alzheimer Disease
Neurodegenerative Diseases
Drug: Placebo
Drug: Donanemab

Phase 3

Lilly
Lilly

Warszawa, Mazowieckie, Poland and 142 other locations

The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC in adult participants with agitation related to Alzheimer's...

Begins enrollment this month
Alzheimer Disease
Drug: Placebo
Drug: Xanomeline Enteric Capsule

Phase 3

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Sochaczew, Poland and 189 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems